This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Class I drugs in paroxysmal atrial fibrillation

Authoring team

Flecainide is effective in reducing the recurrence of symptomatic paroxysmal atrial fibrillation. Adverse effects are common but usually tolerable. There is concern about increased mortality with flecainide especially following myocardial infarction.

Propafenone may also be effective in paroxysmal atrial fibrillation.


Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.